Press Releases

Press Releases

September 20, 2022
SAN DIEGO , Sept. 20, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of nine abstracts at the 2022 American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2022, being held November 10-14, 2022 ,
August 4, 2022
Records in AVISE® CTD Volume, Ordering Healthcare Providers and Adopters SAN DIEGO , Aug. 04, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2022 .
July 21, 2022
SAN DIEGO , July 21, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended June 30, 2022 , after the market close on Thursday, August 4, 2022 . Ron Rocca , Exagen’s President and Chief Executive
June 9, 2022
SAN DIEGO , June 09, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the addition of Exagen Inc. to MediNcrease Health Plans, LLC’s national provider network, providing enhanced care to their approximately 7.5 million
Displaying 1 - 10 of 23